rallis india management meet update aug 2011

Upload: rajeevchebolu

Post on 14-Apr-2018

216 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/30/2019 Rallis India Management Meet Update Aug 2011

    1/5Emkay Global Financial Services Ltd 1

    August 17, 2011

    Reco

    Buy

    Previous Reco

    BuyCMP

    Rs 167

    Target Price

    Rs 209

    EPS change FY12E/13E (%) NA

    Target Price change (%) NA

    Nifty 5,036

    Sensex 16,731

    Price Performance

    (%) 1M 3M 6M 12M

    Absolute 9 20 32 29

    Rel. to Nifty 21 31 44 39

    Source: Bloomberg

    Relative Price Chart

    100

    115

    130

    145

    160

    175

    Aug-10 Oct-10 Dec-10 Feb-11 Apr-11 Jun-11

    Rs

    -20

    -8

    4

    16

    28

    40%

    Rallis India (LHS) Rel to Nifty (RHS)

    Source: Bloomberg

    Stock DetailsSector Agri Input & Chemicals

    Bloomberg RALI@IN

    Equity Capital (Rs mn) 194

    Face Value(Rs) 1

    No of shares o/s (mn) 194

    52 Week H/L 174/117

    Market Cap (Rs bn/USD mn) 33/728

    Daily Avg Volume (No of sh) 187041

    Daily Avg Turnover (US$mn) 0.7

    Shareholding Pattern (%)

    Jun-11 Mar-11 Dec-10

    Promoters 50.7 50.7 50.7

    FII/NRI 6.5 4.2 3.2

    Institutions 19.0 21.0 21.1

    Private Corp 4.6 3.7 4.1

    Public 19.3 20.4 20.9

    Source: Capitaline

    Rohan Gupta

    [email protected]

    +91 22 6612 1248

    Balwindar Singh

    [email protected]

    +91 22 6612 1272

    We met with the management of Rallis India on 16th

    August, 2011. Here

    are the key takeaways-

    Industry growth to remain buoyant at 12-15% in long run

    Domestic agrochemical industry has grown at 12-15% pa in last 3-4 years and the

    management sounded confident about the sustainability of such growth in long term (5-

    6 years) despite growing base affect. Lower per acre consumption of agrochemicals in

    India (less than 1 kg / acre as against 6-10 kgs in various other markets), increasing

    affordability factors (thanks to rising MSPs across the crops) of the farmers, increasing

    education among the farmers (many programmes being organised by the various

    companies to educate the farmers about the adequate use of various agri inputs),

    launches of various new products in the market along with many other factors are likely

    to contribute to sustainable growth of agrochemicals in the country.

    Aggressive initiatives and agri reforms undertaken by few states like Gujarat,

    Maharashtra, Chhatisgarh and Bihar have resulted in higher growth in these states.Other states are also likely to step up reforms in their respective states which will drive

    growth in agrochemicals.

    Higher demand from herbicide to drive growth in agrochemicals

    Herbicides comprises of ~20% of agrochemicals market in India (approx Rs 75 bn) while

    globally herbicides accounts for 40-50% of total agrochemicals market. With rising

    labour cost in India and growing unavailability of labour, mainly driven by NREGA,

    farmers are switching from manual weeding to herbicides. Consequently, herbicide is

    growing at a faster pace of 25-30% as against industry growth of ~15%. The higher

    growth in herbicides is likely to continue on account of increasing labor cost.

    Rallis- playing aggressively in launch of herbicide products

    Though Rallis has been a late entrant in herbicide markets; it has been recently very

    aggressive in launching new products in herbicides. Among the three products launched

    in FY12 (Neon (I), Sonic (I) and Vaar (H) and products to be launched in near future

    Honcho (H), Cylo (H) and Saras (F)), three are herbicides. Herbicides products

    launched in previous year like Tarak are doing well.

    Q1FY12 results strengthens our conviction

    Rallis India reported consolidated revenues of Rs 3.0bn, +47% yoy, higher than est of

    Rs 2.7bn. This was primarily on account of higher than expected revenue contribution of

    Metahelix, the seed business, in which Rallis acquired 53.5% stake in December 2010.

    Rallis reported consolidated EBITDA of Rs 435mn, +92%yoy, led by higher EBITDA

    margins in Metahelix. Consolidated APAT of Rs 231mn, +56% yoy, was higher than est

    of Rs 136mn.

    We remain positive and maintain BUY on the stock

    Our view on the industry / company is broadly in line with managements view. We

    expect growth in the agrochemicals industry to remain strong and Rallis being a market

    leader in many segments will continue to outperform. We estimate revenue CAGR

    (FY10-13E) of 20% and PAT CAGR of 30% with FY12E/FY13E EPS of Rs 8.9 / Rs 11.6.

    We have a BUY recommendation on the stock with price target of Rs 209 (18X FY13).

    Financial Snapshot Rs Mn

    YE-Mar Net EBITDA EPS EPS RoE EV/

    Sales (Core) (%) PAT (Rs) % chg (%) P/E EBITDA P/BV

    FY10 8,787 1,562 17.8 1,114 5.0 62.2 26.1 32.5 21.5 7.7

    FY11 10,657 1,713 16.1 1,264 6.5 29.7 27.2 25.7 19.4 6.4

    FY12E 13,086 2,563 19.6 1,722 8.9 36.2 30.3 18.9 13.0 5.2

    FY13E 15,520 3,322 21.4 2,249 11.6 30.6 31.5 14.5 9.7 4.1

    ManagementM

    eetUpdate

    Rallis India

    Industry growth to remain buoyant

  • 7/30/2019 Rallis India Management Meet Update Aug 2011

    2/5

    Rallis India Management Meet Update

    Emkay Research 17 August 2011 2

    Continues to screen inorganic opportunities in agrochemical space

    While sharing its outlook on inorganic opportunities in the sector, management indicated

    that they were screening opportunities in domestic / global market in agrochemical space.

    Their seed business is likely to be driven by growth in Metahelix with not too much focus on

    any further near term acquisition in seeds, since companys strategy is to exploit the

    potential of Metahelix in the near future. However agrochemicals, especially chemicals

    remains focus area for acquisitions.

    Dahej facility to benefit from rising manufacturing cost in China

    Potential from recently commissioned Dahej facility can only be captured over a period of

    time. Management maintained its cumulative revenue target of Rs5 bn over 5 years from

    Dahej. Dahej initially will cater to Active Ingredients (AIs) and primarily to exports market,

    however later on rising share of formulations (higher realisations and higher margins

    business) will drive its revenues and profitability.

    India as a country has ample growth opportunities in agrochemical exports / CRAMs

    market. India also has a favorable advantage over China because of rising cost in China

    due to factors like rising environment cost, higher power cost and increasing labour cost.

    Rallis sees strong growth opportunities in such export markets and Dahej facility is likely totap potential from growing opportunities in future.

    Seeds Business- in line with management expectations

    Though companys seed business surprised investor community in Q1FY12 (with revenues

    of Rs 593 mn, EBITDA margins of 20.6% and PBT contribution of Rs 111 mn) but the same

    was in line with managements target. Seeds being seasonal business (Q1 being the best

    quarter) and Metahelix, with strong product portfolio of kharif crops performed well in 1st

    quarter. However subsequent quarter performance is likely to remain subdued.

    Metahelix is likely to launch its BT cotton hybrid CRY 1 in next 1-2 years which should

    add to companys performance. However, they did not pegg any number to revenue

    potential from this.

    Rallis enjoys strong brand positioning & brand loyalty

    Rallis enjoys strong brand positioning among its peers in the crop protection market. 8

    of the top 12 crop protection products in 2010 were under Rallis brand. This compares

    favorably with 2009 when 7 Rallis brands were among top 12.

    Brand Positioning in Indian Crop Protection Market

    Brand Names Company

    Confidor Bayer

    Asataf Rallis

    Rogor Rallis

    Tata Mida Rallis

    Contaf Rallis

    Antracol Bayer

    Thiodon Bayer

    Contaf Plus Rallis

    Tata Mono Rallis

    Tata Fen Rallis

    Fujion Rallis

    Bilzeb Bayer

    Hostathion Bayer

    Larvin Bayer

    Metacid Bayer

    Source: Company presentation, Emkay Research

  • 7/30/2019 Rallis India Management Meet Update Aug 2011

    3/5

    Rallis India Management Meet Update

    Emkay Research 17 August 2011 3

    Monsoon picks up- bodes well for Rallis

    Management indicated that monsoon has picked up pace in the latter half of July resulting

    into normal sowings. Paddy sowing is normal in Northern & Eastern India though it has

    been delayed in South India. Cotton sowing is normal in North India but it has been delayed

    in Gujarat/Maharashtra. Improvement in monsoons towards the second half bodes well for

    Rallis and we expect company to benefit from the rising demand for agrochemicals.

    Crop Normal area for Area sown 2010 % % of

    whole kharif on 15thJuly,2011 Change normal Area

    Rice 394 115 115 0% 29%

    Pulses 107 36 43 -16% 34%

    Sugarcane 45 51 49 5% 114%

    Oilseeds 177 99 102 -4% 56%

    Cotton 94 59 84 -30% 63%

    Oilseeds

    Soyabean 96 74 65 14% 77%

    Groundnut 56 19 30 -37% 34%

    Sesame 18 5 4 9% 26%

    Pulses

    Red Gr 36 12 19 -37% 34%

    Green Gr 26 8 11 -31% 30%

    Black Gr 23 8 9 -9% 35%

    Source: Company presentation, Emkay Research

  • 7/30/2019 Rallis India Management Meet Update Aug 2011

    4/5

    Rallis India Management Meet Update

    Emkay Research 17 August 2011 4

    Key Financials

    Income Statement Balance Sheet

    Y/E, Mar (Rs. mn) FY10 FY11 FY12E FY13E Y/E, Mar (Rs. mn) FY10 FY11 FY12E FY13E

    Net Sales 8,787 10,657 13,086 15,520 Equity share capital 130 194 194 194

    Growth (%) 5.5 21.3 22.8 18.6 Reserves & surplus 4,115 4,855 6,111 7,798

    Expenditure 7,225 8,944 10,524 12,199 Net worth 4,245 5,049 6,306 7,993

    Materials Consumed 5,034 6,283 7,669 8,971 Minority Interest 0 21 21 21

    Employee Cost 667 696 833 900 Secured Loans 16 1,087 1,087 1,087

    Other Exp 1,524 1,762 2,022 2,328 Unsecured Loans 65 85 85 85

    EBITDA 1,562 1,713 2,563 3,322 Loan Funds 81 1,172 1,172 1,172

    Growth (%) 45.9 9.7 49.6 29.6 Net deferred tax liability (53) 32 32 32

    EBITDA margin (%) 17.8 16.1 19.6 21.4 Total Liabilities 4,272 6,275 7,532 9,219

    Depreciation 183 175 265 287

    EBIT 1,378 1,539 2,298 3,035 Gross Block 3,091 4,057 5,751 6,151

    EBIT margin (%) 15.7 14.4 17.6 19.6 Less: Depreciation 1,564 1,743 2,007 2,294

    Other Income 275 346 216 233 Net block 1,527 2,314 3,744 3,858

    Interest expenses 27 40 54 54 Capital work in progress 1,120 1,695 400 400

    PBT 1,626 1,845 2,460 3,213 Goodwill - 1,236 1,236 1,236

    Tax 512 580 738 964 Investment 1,402 256 256 256

    Effective tax rate (%) 31.5 31.5 30.0 30.0 Current Assets 3,263 4,666 4,968 7,141

    Adjusted PAT 1,114 1,264 1,722 2,249 Inventories 1,489 2,289 2,330 2,977

    Growth (%) 64.2 13.5 36.2 30.6 Sundry debtors 755 1,064 1,362 1,701

    Net Margin (%) 12.7 11.9 13.2 14.5 Cash & bank balance 119 146 108 1,296

    (Profit)/loss from JVs/Ass/MI - - - - Loans & advances 886 1,154 1,154 1,154

    Adj. PAT After JVs/Ass/MI 1,114 1,264 1,722 2,249 Other current assets 15 13 13 13

    E/O items (14) - - - Current lia & Prov 3,041 3,891 3,073 3,672

    Reported PAT 1,099 1,264 1,722 2,249 Current liabilities 2,595 3,306 2,510 2,977

    PAT after MI 1,114 1,264 1,722 2,249 Provisions 446 586 564 695

    Growth (%) 64.2 13.5 36.2 30.6 Net current assets 222 774 1,895 3,469

    Total Assets 4,272 6,275 7,532 9,219

    Cash Flow Key Ratios

    Y/E, Mar (Rs. mn) FY10 FY11 FY12E FY13E Y/E, Mar FY10 FY11 FY12E FY13E

    PBT (Ex-Other income) 1,527 1,845 2,460 3,213 Profitability (%)

    Depreciation 183 175 265 287 EBITDA Margin 16.5 16.1 19.6 21.4

    Interest Provided 23 25 54 54 Net Margin 11.4 11.9 13.2 14.5

    Other Non-Cash items 9 (124) (57) 132 ROCE 36.6 35.8 36.5 39.1

    Chg in working cap 1,077 (236) (1,136) (518) ROE 26.1 27.2 30.3 31.5

    Tax paid -667 -697 -738 -964 RoIC 62.6 53.2 42.2 43.4

    Operating Cashflow 2,152 987 848 2,204 Per Share Data (Rs)

    Capital expenditure (949) (1,378) (400) (400) EPS 5.0 6.5 8.9 11.6

    Free Cash Flow 1,203 -391 448 1,804 CEPS 6.1 7.4 10.2 13.0Other income 8 54 - - BVPS 21.8 26.0 32.4 41.1

    Investments 28 (116) - - DPS 1.2 2.0 2.2 2.9

    Investing Cashflow 36 -63 0 0 Valuations (x)

    Equity Capital Raised 9 - - - PER 32.5 25.7 18.9 14.5

    Loans Taken / (Repaid) (744) 849 - - P/CEPS 27.5 22.6 16.4 12.8

    Interest Paid (28) (39) (54) (54) P/BV 7.7 6.4 5.2 4.1

    Dividend paid (incl tax) (440) (357) (431) (562) EV / Sales 3.5 3.1 2.5 2.1

    Income from investments 0 0 0 0 EV / EBITDA 21.5 19.4 13.0 9.7

    Others (2) - - - Dividend Yield (%) 1.0 0.6 0.7 1.2

    Financing Cashflow -1,205 453 -485 -617 Gearing Ratio (x)

    Net chg in cash 35 -1 -37 1,188 Net Debt/ Equity (0.3) 0.2 0.1 (0.0)

    Opening cash position 84 119 146 108 Net Debt/EBIDTA (1.0) 0.4 0.3 (0.1)

    Closing cash position 119 146 108 1,296 Working Cap Cycle (days) (15) 2 33 40

  • 7/30/2019 Rallis India Management Meet Update Aug 2011

    5/5

    Rallis India

    Emkay Research 17 August 2011

    Recommendation History: Rallis India RALI IN

    Date Reports Reco CMP Target

    22/07/2011 Rallis India Q1FY12 Result Update Buy 159 209

    02/05/2011 Rallis India Q4FY11 Result Update Buy 1,390 1,735

    18/01/2011 Rallis India Q3FY11 Result Update Buy 1,313 1,800

    27/12/2010 Rallis India Management Meet Update Buy 1,391 1,800

    Recent Research Reports

    Date Reports Reco CMP Target

    09/08/2011 Deepak Fertilisers Q1FY12 Result Update Buy 160 250

    09/08/2011 Tata Chemicals Q1FY12 Result Update Accumulate 351 400

    02/08/2011 Tamilnadu Newsprint Q1FY12 Result Update Buy 118 180

    29/07/2011 United Phosphorus Q1FY12 Result Update Buy 166 215

    DISCLAIMER:This document is not for public distribution and has been furnished to you solely for your information and may not be reproduced or redistributed to any other person. The mannerof circulation and distribution of this document may be restricted by law or regulation in certain countries, including the United States. Persons into whose possession this document may come arerequired to inform themselves of, and to observe, such restrictions. This material is for the personal information of the authorized recipient, and we are not soliciting any action based upon it. Thisreport is not to be construed as an offer to sell or the solicitation of an offer to buy any security in any jurisdiction where such an offer or solicitation would be illegal. No person associated with EmkayGlobal Financial Services Ltd. is obligated to call or initiate contact with you for the purposes of elaborating or following up on the information contained in this document. The material is based uponinformation that we consider reliable, but we do not represent that it is accurate or complete, and it should not be relied upon. Neither Emkay Global Financial Services Ltd., nor any person connectedwith it, accepts any liability arising from the use of this document. The recipient of this material should rely on their own investigations and take their own professional advice. Opinions expressed areour current opinions as of the date appearing on this material only. While we endeavor to update on a reasonable basis the information discussed in this material, there may be regulatory, compliance,or other reasons that prevent us from doing so. Prospective investors and others are cautioned that any forward-looking statements are not predictions and may be subject to change without notice.We and our affiliates, officers, directors, and employees world wide, including persons involved in the preparation or issuance of this material may; (a) from time to time, have long or short positions in,and buy or sell the securities thereof, of company (ies) mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a

    market maker in the financial instruments of the company (ies) discussed herein or may perform or seek to perform investment banking services for such company(ies)or act as advisor or lender /borrower to such company(ies) or have other potential conflict of interest with respect to any recommendation and related information and opinions. The same persons may have acted upon theinformation contained here. No part of this material may be duplicated in any form and/or redistributed without Emkay Global Financial Services Ltd.'s prior written consent. No part of this documentmay be distributed in Canada or used by private customers in the United Kingdom. In so far as this report includes current or historical information, it is believed to be reliable, although its accuracy andcompleteness cannot be guaranteed.

    Emkay Global Financial Services Ltd.Paragon Center, H -13 -16, 1st Floor, Pandurang Budhkar Marg, Worli, Mumbai 400 013. Tel No. 6612 1212. Fax: 6624 2410

    www.emkayglobal.com

    Management Meet Update

    http://reports.emkayshare.com/downloads/researchreports/Rallis%20India%20Q1FY12%20Result%20Update.pdfhttp://reports.emkayshare.com/downloads/researchreports/Rallis%20India%20Q4FY11%20Result%20Update.pdfhttp://reports.emkayshare.com/downloads/researchreports/Rallis%20India%20Q3FY11%20Result%20Update.pdfhttp://reports.emkayshare.com/downloads/researchreports/Rallis%20India%20Management%20Meet%20Update_271210.pdfhttp://reports.emkayshare.com/downloads/researchreports/Deepak%20Fertilisers%20Q1FY12%20Result%20Update.pdfhttp://reports.emkayshare.com/downloads/researchreports/Tata%20Chemicals%20Q1FY12%20Result%20Update.pdfhttp://reports.emkayshare.com/downloads/researchreports/Tamilnadu%20Newsprint%20Q1FY12%20Result%20Update.pdfhttp://reports.emkayshare.com/downloads/researchreports/United%20Phosphorus%20Q1FY12%20Result%20Update.pdfhttp://reports.emkayshare.com/downloads/researchreports/United%20Phosphorus%20Q1FY12%20Result%20Update.pdfhttp://reports.emkayshare.com/downloads/researchreports/Tamilnadu%20Newsprint%20Q1FY12%20Result%20Update.pdfhttp://reports.emkayshare.com/downloads/researchreports/Tata%20Chemicals%20Q1FY12%20Result%20Update.pdfhttp://reports.emkayshare.com/downloads/researchreports/Deepak%20Fertilisers%20Q1FY12%20Result%20Update.pdfhttp://reports.emkayshare.com/downloads/researchreports/Rallis%20India%20Q4FY11%20Result%20Update.pdfhttp://reports.emkayshare.com/downloads/researchreports/Rallis%20India%20Q1FY12%20Result%20Update.pdfhttp://reports.emkayshare.com/downloads/researchreports/Rallis%20India%20Management%20Meet%20Update_271210.pdfhttp://reports.emkayshare.com/downloads/researchreports/Rallis%20India%20Q3FY11%20Result%20Update.pdf